Live stream preview
05/27/2021 - Dr. Ronald Chen - Radiation Oncology - GU
Chartrounds US - GU
•
35m
Unfavorable intermediate risk prostate cancer, doubling time of 10.4 months, RT proctitis, SBRT, treatment,
Up Next in Chartrounds US - GU
-
06/08/2021 - Dr. Howard Sandler - Rad...
Revolutionary vs. Evolutionary: adjuvant vs neoadjuvant ADT, research in PSMA technology, radiation for oligometastatic prostate cancer
-
06/24/2021 - Dr. Ronald Chen - Radiat...
oral agent vs. injection HERO trial, timing of RT, IMRT radiotherapy, salvage radiation, dose, ADT tradeoffs, prostate ca
-
07/13/2021 - Dr. Howard Sandler - Rad...
Postprostatectomy salvage radiotherapy, ADT and SBRT, seminal vesicle invasion, seminal vesicle MRI readings, nodal radiation
